Introduction
Successful implantation and continued development of implanted embryos depend on a complex series of cellular and molecular changes induced in the preimplantation uterus by oestrogen and progesterone (Shelesnyak, 1955;  Psychoyos, 1973; Short, 1984) . Several recent findings suggest that some hormone-dependent changes may be due to local actions of polypeptide growth factors, such as epidermal growth factor and insulin-like growth factor 1 (DiAugustine et al, 1988; Murphy et al, 1988; Brigstock et al, 1989; Croze et al, 1990; Huet-Hudson et Nelson et al, 1991) . These and related factors may function as autocrine or paracrine regulators of uterine cell proliferation and differentiation. The pro-inflammatory cytokines IL-1, and TNF-constitute another group of locally acting polypeptide growth factors, which are powerful stimulators of cell proliferation, differentiation and programmed cell death (Billingham, 1987;  Balkwill and Burke, 1989;  Dinarello, 1989; Durum and Oppenheim, 1989) . IL-1, and TNF-and factors that they secondarily induce, such as prostaglandins, leukotrienes, histamine and other cytokines, are mediators of host inflammatory responses to pathogenic stimuli and are essential cofactors in immune responses (Billingham, 1987; Balkwill and Burke, 1989;  Dinarello, 1989; Durum and Oppenheim, 1989) . Until recently, studies of cytokine expression and func¬ tion were limited to pathological conditions, e.g. responses to endotoxin.
In situ hybridization showed IL-la and IL-1 ß mRNA transcripts in the endometrium of the uterus of nonpregnant mice, whereas IL-1 expression would not be detected in other normal tissues, suggesting that, during the oestrous cycle, IL-1 production was higher in the uterus than in other organs (Takacs et al, 1988) . High concentrations of IL-1, IL-6 and TNF-were detected in the mouse uterus on days 1 and 2 of pregnancy . Cytokine production accompanied the post-mating intrauterine acute inflammatory response (Lobel et al, 1967; De et al, 1991) . To determine whether cytokines are also expressed in the uterus during the peri-implantation period of pregnancy, we determined IL-1, and TNF-gene Frozen tissue from ten mice for uterus and four mice for liver was homogenized using a polytron, and total RNA was isolated from tissue by the guanidine isothiocyanate method (Han et al, 1987) . RNA was isolated from two groups of mice. Poly(A) RNA was isolated from total RNA from one of the groups by adsorption to and elution from oligo (dt) cellulose (type 3) (Aviv and Leder, 1972) . The mRNA yield from the poly(A) columns was uniform, ranging from 2 to 3% of the total RNA in each sample. cDNA clones for murine IL- (Lomedico et al, 1984) , IL-lß (Huang et al, 1988) , (Melton et al, 1984) . RNA in individual samples was measured by UV absorbance at 260 nm. Cytokine-specific mRNA was localized in all samples by northern blotting (Andrews et al, 1987) . The (Fig. 2) . The concentration of IL-lß mRNA decreased progres¬ sively from day 5 to day 9. (Fig. 3) and TNF-mRNA were detected in each sample from each day. The concentration of IL-6 mRNA increased progressively from its lowest point on day 3 to a high on day 6, decreased until day 8 and then increased again on day 9. The concentration of TNF-mRNA also increased from a low point on days 3 and 4 to a high on day 6, then decreased until day 9 (Fig. 4) (Fig. 5a ). The IL-1 concentration increased to peak values on day 4, and then decreased progressively to day 6. Tissue extracts were obtained from pregnant mice in the morning and afternoon of day 4. The concentration of bioactive IL-1 in the two samples was nearly identical. The difference in activity between days 4 and 6 was statistically significant (P < 0.001). The IL-1 concentration increased pro¬ gressively from day 6 to day 9 and the difference between the values obtained on days 6 and 9 was statistically significant (P < 0.001).
A high concentration of IL-6 bioactivity was present in the tissue on day 3, and the concentration increased to a peak on day 5 (Fig. 5b) . After decreasing on days 6 and 7, the tissue IL-6 concentration increased progressively until day 9.
TNF-bioactivity increased progressively to its highest concentration on day 8 and remained high until day 9 (Fig. 5 c) .
The differences between the concentration detected on day 3 Fig. 3 . Northern blot for mouse interleukin 6 (IL-6). The control (C) lane contains 1.1 pg of total RNA from lipopolysaccharide-stimulated J774 cells (macrophage cell line). Other lanes (D3-D9) contain 2.2 pg of uterine poly(A) RNA from mice killed on days 3-9 of pregnancy, (a) Northern blot, (b) spectrodensitometric analysis and (c) acridineorange-stained gel containing 1.1 pg of control cell RNA (C) or 6.6 pg of the uterine RNA from which the poly(A) RNA was prepared (D3-D9). and concentrations detected on days 4-7 were statistically significant (P < 0.001). The differences between the concen¬ trations detected on days 3-7 and the concentrations detected on days 8 and 9 were also statistically significant (P < 0.001).
Immunocytochemical detection of IL-1, IL-6 and TNF-in uterine cells An independent analysis of cytokine gene products in uterine tissue was provided by identifying IL-1, IL-6 and TNF-in isolated uterine cells using cytokine-specific polyclonal anti¬ bodies. IL-1, IL-6 and TNF-were detected in uterine cells on each day tested (Table 1 ). The IL-1 staining intensity varied substantially from day to day. Cells were strongly stained for IL-1 on day 4 and on days 7-9, but only weakly stained on the other days (Fig. 6, Table 1 ). Cells were strongly positive for and TNF-on days [3] [4] [5] [6] [7] [8] [9] (Fig. 6 were unstained, some cells were stained evenly throughout their cytoplasm and the majority of the cells exhibited strong peripheral staining (Fig. 6a-c) . In contrast, in anti-TNF-a stained populations, a few cells were unstained, while the remainder were homogeneously stained (Fig. 6d) 
Discussion
The present studies demonstrated expression of genes for IL-1, IL-6 and TNF-in the uterus during the peri-implantation (Shelesnyak, 1955; Yoshinaga et al, 1969; Psychoyos, 1973; Short, 1984 preceded TNF- (Billingham, 1987;  Balkwill and Burke, 1989; Dinarello, 1989; Durum and Oppenheim, 1989) . The delayed expression of and TNFrelative to IL-1 was consistent with observations in other systems that IL-1 is an autocrine and paracrine inducer of and TNF- (Billingham, 1987; Balkwill and Burke, 1989; Dinarello, 1989; Durum and Oppenheim, 1989 .
The current study provided no insight into the cell source for any of the intrauterine cytokines. However, the findings may be related to previous reports that oestrogen induces IL-1 produc¬ tion in cultured macrophages (Flynn, 1986; Hu et al, 1988;  localized IL-1 and TNF-a-producing cells to the subepithelial stroma in nonpregnant mice (Takacs et al, 1988) , the subepithelial stroma early in pregnancy (McMaster et al, 1992) and the peridecidual region during the peri-implantation period. Those are areas where macrophages are concentrated .
If increased cytokine production in the uterus was due solely to direct stimulation of macrophage IL-1 transcription and translation by oestrogen and progesterone (Flynn, 1986; Hu et al, 1988; Polan et al, 1988; De et al, 1992) , cytokine con¬ centrations should have been high in all tissues. There was no evidence for increased cytokine mRNA expression in the liver and previous surveys of normal animals provided no support for cyclic expression of cytokine genes in other normal tissues (Billingham, 1987; Takacs et al, 1988; Balkwill and Burke, 1989; Dinarello, 1989; Durum and Oppenheim, 1989 ). Those data demonstrate, but do not explain, tissue-specific increases in cytokine production in the uterus during pregnancy.
Many pathologic events involve a common cascade of tissue changes, including increased vascular permeability, vasodilation, cell proliferation, cell differentiation, cell death and fibrosis. Those inflammatory changes are mediated by factors that include pro-inflammatory cytokines and TNF-), prostaglandins, leukotrienes, histamine, fibroblast growth fac¬ tor, platelet-derived growth factor and the transforming growth factors (Billingham, 1987; Balkwill and Burke, 1989; Dinarello, 1989; Durum and Oppenheim, 1989) . Each of those factors is regulated, at least in part, by IL-1 (Dinarello, 1989; Di Giovine and Duff, 1990) . Two of the IL-1-induced factors, prostaglan¬ dins and histamine, are essential components in the preparation of the uterus for implantation (Shelesnyak, 1955;  Kennedy, 1977; Malathy et al, 1986) . Although blastocyst implantation is a normal physiological event and the intrauterine changes that surround implantation are neither pathologic nor resemble acute or chronic inflammation, the possible role of IL-1 and factors induced by IL-1 in preparation of the uterus for implantation merits further investigation.
